Hepatic senescence marker protein-30 is involved in the progression of nonalcoholic fatty liver disease

Journal of Gastroenterology

Volumn 45, Issue 4, 2010, Pages 426-434

  Park, Hyohun ^a,d   Ishigami, Akihito ^b,c   Shima, Toshihide ^a   Mizuno, Masayuki ^a   Maruyama, Naoki ^c   Yamaguchi, Kanji ^d   Mitsuyoshi, Hironori ^d   Minami, Masahito ^d   Yasui, Kohichiroh ^d   Itoh, Yoshito ^d   Yoshikawa, Toshikazu ^d   Fukui, Michiaki ^d   Hasegawa, Goji ^d   Nakamura, Naoto ^d   Ohta, Mitsuhiro ^e   Obayashi, Hiroshi ^f   Okanoue, Takeshi ^a,d  

^a Saiseikai Imperial Gift Foundation Inc Saiseikai Suita Hospital   (Japan)

^b TOHO UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^e KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^f Institute of Bio Response Informatics   (Japan)

Author keywords

Insulin resistance; NAFLD; NASH; Oxidative stress; SMP30

Indexed keywords

4 HYDROXYNONENAL; COLLAGEN TYPE 4; INSULIN; LOW DENSITY LIPOPROTEIN; REGUCALCIN; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; LIVER BIOPSY; LIVER FIBROSIS; LIVER LEVEL; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; THROMBOCYTE COUNT;

ADULT; AGED; ALDEHYDES; CALCIUM-BINDING PROTEINS; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; DISEASE PROGRESSION; FATTY LIVER; FEMALE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PLATELET COUNT;

EID: 77953324291     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-009-0154-3     Document Type: Article

References (33)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;18:1221-31.
2. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387-95.
3. Farrell GC. Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region? J Gastroenterol Hepatol. 2003;18:124-38.
4. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980;55:434-8.
5. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313-21.
6. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467-74.
7. Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, et al. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology. 2002;35:373-9.
8. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 2001;120:1183-92.
9. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology. 1998;114:842-5.
10. Fujita T, Uchida K, Maruyama N. Purification of senescence marker protein-30 (SMP30) and its androgen-independent decrease with age in the rat liver. Biochim Biophys Acta. 1992; 1116:122-8.
11. Ishigami A, Maruyama N. Significance of SMP30 in gerontology. Geriatr Gerontol Int. 2007;7:316-25.
12. Fujita T, Inoue H, Kitamura T, Sato N, Shimosawa T, Maruyama N. Senescence marker protein-30 (SMP30) rescues cell death by enhancing plasma membrane Ca(2+)-pumping activity in Hep G2 cells. Biochem Biophys Res Commun. 1998;250:374-80.
13. Inoue H, Fujita T, Kitamura T, Shimosawa T, Nagasawa R, Inoue R, et al. Senescence marker protein-30 (SMP30) enhances the calcium efflux from renal tubular epithelial cells. Clin Exp Nephrol. 1999;3:261-7.
14. Kondo Y, Inai Y, Sato Y, Handa S, Kubo S, Shimokado K, et al. Senescence marker protein 30 functions as gluconolactonase in L-ascorbic acid biosynthesis, and its knockout mice are prone to scurvy. Proc Natl Acad Sci USA. 2006;103:5723-8.
15. Ishigami A, Fujita T, Handa S, Shirasawa T, Koseki H, Kitamura T, et al. Senescence marker protein-30 knockout mouse liver is highly susceptible to tumor necrosis factor-alpha-and Fas-mediated apoptosis. Am J Pathol. 2002;161:1273-81.
16. Ishigami A, Kondo Y, Nanba R, Ohsawa T, Handa S, Kubo S, et al. SMP30 deficiency in mice causes an accumulation of neutral lipids and phospholipids in the liver and shortens the life span. Biochem Biophys Res Commun. 2004;315:575-80.
17. Sato T, Seyama K, Sato Y, Mori H, Souma S, Akiyoshi T, et al. Senescence marker protein-30 protects mice lungs from oxidative stress, aging, and smoking. Am J Respir Crit Care Med. 2006; 174:530-7.
18. Son TG, Zou Y, Jung KJ, Yu BP, Ishigami A, Maruyama N, et al. SMP30 deficiency causes increased oxidative stress in brain. Mech Ageing Dev. 2006;127:451-7.
19. Kondo Y, Sasaki T, Sato Y, Amano A, Aizawa S, Iwama M, et al. Vitamin C depletion increases superoxide generation in brains of SMP30/GNL knockout mice. Biochem Biophys Res Commun. 2008;377:291-6.
20. Sato Y, Kajiyama S, Amano A, Kondo Y, Sasaki T, Handa S, et al. Hydrogen-rich pure water prevents superoxide formation in brain slices of vitamin C-depleted SMP30/GNL knockout mice. Biochem Biophys Res Commun. 2008;375:346-50.
21. Okazaki M, Usui S, Ishigami M, Sakai N, Nakamura T, Matsuzawa Y, et al. Identification of unique lipoprotein subclasses for visceral obesity by component analysis of cholesterol profile in high-performance liquid chromatography. Arterioscler Thromb Vasc Biol. 2005;25:578-84.
22. Okazaki M, Usui S, Fukui A, Kubota I, Tomoike H. Component analysis of HPLC profiles of unique lipoprotein subclass cholesterols for detection of coronary artery disease. Clin Chem. 2006;52:2049-53.
23. Poli G. Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med. 2000;21:49-98.
24. Matsuoka M, Tsukamoto H. Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: implication for a pathogenetic role in alcoholic liver fibrogenesis. Hepatology. 1990;11:599-605.
25. Tomita K, Oike Y, Teratani T, Taguchi T, Noguchi M, Suzuki T, et al. Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice. Hepatology. 2008;48:458-73.
26. Parola M, Pinzani M, Casini A, Albano E, Poli G, Gentilini A, et al. Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha 1 (I) gene expression in human liver fat-storing cells. Biochem Biophys Res Commun. 1993;194:1044-50.
27. Parola M, Pinzani M, Casini A, Leonarduzzi G, Marra F, Caligiuri A, et al. Induction of procollagen type I gene expression and synthesis in human hepatic stellate cells by 4-hydroxy-2,3-nonenal and other 4-hydroxy-2,3-alkenals is related to their molecular structure. Biochem Biophys Res Commun. 1996;222:261-4.
28. Park JK, Jeong DH, Park HY, Son KH, Shin DH, Do SH, et al. Hepatoprotective effect of Arazyme on CCl4-induced acute hepatic injury in SMP30 knock-out mice. Toxicology. 2008;246:132-42.
29. Jeong DH, Goo MJ, Hong IH, Yang HJ, Ki MR, Do SH, et al. Inhibition of radiation-induced apoptosis via overexpression of SMP30 in Smad3-knockout mice liver. J Radiat Res (Tokyo). 2008;49:653-60.
30. Griffin BA, Packard CJ. Metabolism of VLDL and LDL subclasses. Curr Opin Lipidol. 1994;5:200-6.
31. Packard CJ. Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein. Biochem Soc Trans. 2003;31(Pt 5):1066-9.
32. Adiels M, Borén J, Caslake MJ, Stewart P, Soro A, Westerbacka J, et al. Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia. Arterioscler Thromb Vasc Biol. 2005;25:1697-703.
33. Adiels M, Taskinen MR, Packard C, Caslake MJ, Soro-Paavonen A, Westerbacka J, et al. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia. 2006;49:755-65.